- 200 years
- Study
- International
- Business and employers
- Research
- About us
https://webcdn.mmu.ac.uk/profiles/img/profile-images/1Mark-Slevin-0159-crop-145x145-5853fbbb53baf.png
http://www.iccc.cat/
http://www.medivasc.com
Forensic pathologyBiomedical ScienceProteomics and genomics
M. Di Napoli, AR. Parry-Jones, CJ. Smith, SJ. Hopkins, M. Slevin, et al. L. Masotti, V. Campi, P. Singh, F. Papa, A. Popa-Wagner, V. Tudorica, DA. Godoy. (2014). C-reactive protein predicts hematoma growth in intracerebral hemorrhage. Stroke. 45(1), pp.59-65.
M. Slevin, X. Sawkulycz, L. Combes, B. Guo, W-H. Fang, et al. Y. Zeinolabediny, D. Liu, G. Ferris, A. Ludlaim. (2020). Correction to: Laser-Capture Microdissection for Measurement of Angiogenesis After Stroke. Springer New York.
M. Slevin, G. McDowell (2015). Handbook of Vascular Biology Techniques. M. Slevin, G. McDowell. Springer Netherlands.
AS. Kibos, BP. Knight, V. Essebag, SB. Fishberger, M. Slevin, et al. IC. Tintoiu. (2014). Cardiac Arrhythmias. AS. Kibos, BP. Knight, V. Essebag, SB. Fishberger, M. Slevin, IC. Țintoiu. Springer London.
M. Slevin (2011). Therapeutic Angiogenesis for Vascular Diseases. M. Slevin. Springer Netherlands.
RS. Al-Baradie, A. Abdel-Hadi, F. Ahmad, SA. Alsagaby, M. Slevin, et al. W. Alturaiki, Y. Madkhali, BM. Aljarallah, M. Alqahtani, M. Miraj, I. Ahmad, N. Albaradie, R. Albaradie. (2023). Author Correction: Association of monomeric C-Reactive Protein (m-CRP) with hypothalamic neurons after CRP hippo-campal administration in a model of dementia. Eur Rev Med Pharmacol Sci. 27(2),
RS. Al-Baradie, A. Abdel-Hadi, F. Ahmad, SA. Alsagaby, M. Slevin, et al. W. Alturaiki, Y. Madkhali, BM. Aljarallah, M. Alqahtani, M. Miraj, I. Ahmad, N. Albaradie, R. Albaradie. (2022). Association of monomeric C-Reactive Protein (m-CRP) with hypothalamic neurons after CRP hippo-campal administration in a model of dementia. Eur Rev Med Pharmacol Sci. 26(23), pp.8713-8718.
G. Mansueto, M. Di Napoli, CP. Campobasso, M. Slevin (2021). Pulmonary arterial hypertension (PAH) from autopsy study: T-cells, B-cells and mastocytes detection as morphological evidence of immunologically mediated pathogenesis. Pathol Res Pract. 225, pp.153552-153552.
PR. Castro, LFF. Bittencourt, S. Larochelle, SP. Andrade, CR. Mackay, et al. M. Slevin, VJ. Moulin, LS. Barcelos. (2021). GPR43 regulates sodium butyrate-induced angiogenesis and matrix remodeling. Am J Physiol Heart Circ Physiol. 320(3), pp.H1066-H1079.
Y. Zeinolabediny, S. Kumar, M. Slevin (2021). Monomeric C-Reactive Protein - A Feature of Inflammatory Disease Associated With Cardiovascular Pathophysiological Complications?. In Vivo. 35(2), pp.693-697.
F. Caccuri, P. D'Ursi, M. Uggeri, A. Bugatti, P. Mazzuca, et al. A. Zani, F. Filippini, M. Salmona, D. Ribatti, M. Slevin, A. Orro, W. Lu, P. Liò, RC. Gallo, A. Caruso. (2020). Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin. Proceedings of the National Academy of Sciences of the United States of America. 118(2),
G. Ponirakis, T. Elhadd, S. Chinnaiyan, Z. Dabbous, S. Mashhood, et al. H. Al-Muhannadi, I. Petropoulos, A. Khan, KAE. Ashawesh, KMO. Dukhan, ZR. Mahfoud, C. Murgatroyd, M. Slevin, RA. Malik. (2019). Prevalence and risk factors for painful diabetic neuropathy in secondary health care in Qatar. Journal of Diabetes Investigation. 10(6), pp.1558-1564.
RS. Baradie, AM. Algohary, AM. Algohary, ES. Al-Malki, YHS. Babair, et al. AM. Alsulaiman, SA. Alsagaby, M. Slevin. (2019). Can Pharmacological Inhibitors and Antibodies Against m CRP Suppress Interactions with Platelets and Leukocytes-Dampening Inflammation after Stroke. Biomedical Journal of Scientific & Technical Research. 17(5), pp.13084-13089.
W-J. Tu, M. Slevin, X. Zeng (2019). Strategies for Managing the Aging Tsunami in China: Weifang Model. J Am Geriatr Soc. 67(2), pp.403-404.
S. Nava, V. Sordi, L. Pascucci, C. Tremolada, E. Ciusani, et al. O. Zeira, M. Cadei, G. Soldati, A. Pessina, E. Parati, M. Slevin, G. Alessandri. (2019). Long-Lasting Anti-Inflammatory Activity of Human Microfragmented Adipose Tissue. Stem Cells International. 2019,
A. Aljohi, S. Matou-Nasri, D. Liu, N. Al-Khafaji, M. Slevin, et al. N. Ahmed. (2018). Momordica charantia extracts protect against inhibition of endothelial angiogenesis by advanced glycation endproducts in vitro. Food and Function. 11, pp.5728-5739.
V. Caprio, L. Badimon, M. Di Napoli, WH. Fang, GR. Ferris, et al. B. Guo, RS. Iemma, D. Liu, Y. Zeinolabediny, M. Slevin. (2018). pCRP-mCRP dissociation mechanisms as potential targets for the development of small-molecule anti-inflammatory chemotherapeutics. Frontiers in Immunology. 9,
L. Badimon, E. Peña, G. Arderiu, T. Padró, M. Slevin, et al. G. Vilahur, G. Chiva-Blanch. (2018). C-reactive protein in atherothrombosis and angiogenesis. Frontiers in Immunology. 9,
J. Zhu, M. Slevin, B-Q. Guo, S-R. Zhu (2018). Induced pluripotent stem cells as a potential therapeutic source for corneal epithelial stem cells. Int J Ophthalmol. 11(12), pp.2004-2010.
C. Philippa, RI. Miroiu, M. Slevin, EB. Petcu (2018). An update on angiogenesis modulators with a potential therapeutic role. Vascular Cell. 10(1),
Y. Zeinolabediny, F. Caccuri, L. Colombo, F. Morelli, M. Romeo, et al. A. Rossi, S. Schiarea, C. Ciaramelli, C. Airoldi, R. Weston, L. Donghui, J. Krupinski, R. Corpas, E. García-Lara, S. Sarroca, C. Sanfeliu, M. Slevin, A. Caruso, M. Salmona, L. Diomede. (2017). HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders. Scientific Reports. 7(1),
M. Di Napoli, R. Behrouz, CH. Topel, V. Misra, F. Pomero, et al. A. Giraudo, P. Pennati, L. Masotti, FHBM. Schreuder, J. Staals, CJM. Klijn, CJ. Smith, AR. Parry-Jones, MA. Slevin, B. Silver, JZ. Willey, MR. Azarpazhooh, JM. Vallejo, H. Nzwalo, A. Popa-Wagner, DA. Godoy, . MNEMONICH Investigators. (2017). Hypoalbuminemia, systemic inflammatory response syndrome, and functional outcome in intracerebral hemorrhage. J Crit Care. 41, pp.247-253.
RE. Sandu, AT. Balseanu, C. Bogdan, M. Slevin, E. Petcu, et al. A. Popa-Wagner. (2017). Stem cell therapies in preclinical models of stroke. Is the aged brain microenvironment refractory to cell therapy?. Experimental Gerontology. 94, pp.73-77.
R. Behrouz, V. Misra, DA. Godoy, CH. Topel, L. Masotti, et al. CJM. Klijn, CJ. Smith, AR. Parry-Jones, MA. Slevin, B. Silver, JZ. Willey, J. Masjuán Vallejo, H. Nzwalo, A. Popa-Wagner, AR. Malek, S. Hafeez, M. Di Napoli. (2017). Clinical Course and Outcomes of Small Supratentorial Intracerebral Hematomas. Journal of Stroke & Cerebrovascular Diseases : the official journal of National Stroke Association. 26(6), pp.1216-1221.
A. Ruiz-Soler, F. Kabinejadian, MA. Slevin, PJ. Bartolo, A. Keshmiri Optimisation of a novel spiral-inducing bypass graft using computational fluid dynamics. Scientific Reports. 7(1),
E. Peña, R. De La Torre, G. Arderiu, M. Slevin, L. Badimon (2017). mCRP triggers angiogenesis by inducing F3 transcription and TF signalling in microvascular endothelial cells. Thrombosis and Haemostasis. 117(2), pp.357-370.
A. Elosta, M. Slevin, K. Rahman, N. Ahmed (2017). Aged garlic has more potent antiglycation and antioxidant properties compared to fresh garlic extract in vitro. Scientific Reports. 7,
F. Kabinejadian, M. McElroy, A. Ruiz-Soler, HL. Leo, MA. Slevin, et al. L. Badimon, A. Keshmiri. (2016). Numerical Assessment of Novel Helical/Spiral Grafts with Improved Hemodynamics for Distal Graft Anastomoses. PLOS ONE. 11(11),
R. Behrouz, MR. Azarpazhooh, DA. Godoy, MW. Hoffmann, L. Masotti, et al. AR. Parry-Jones, A. Popa-Wagner, FHBM. Schreuder, MA. Slevin, CJ. Smith, M. Di Napoli, . MNEMONICH Steering Committee. (2015). The Multi-National survey on Epidemiology, Morbidity, and Outcomes iN Intracerebral Haemorrhage (MNEMONICH). Int J Stroke. 10(8), pp.E86-E86.
M. Di Napoli, AR. Parry-Jones, CJ. Smith, SJ. Hopkins, M. Slevin, et al. L. Masotti, V. Campi, P. Singh, F. Papa, A. Popa-Wagner, V. Tudorica, DA. Godoy. (2014). C-reactive protein predicts hematoma growth in intracerebral hemorrhage. Stroke. 45(1), pp.59-65.
M. Slevin, M. Baldellou, E. Hill, Y. Alexander, G. McDowell, et al. C. Murgatroyd, M. Carroll, H. Degens, J. Krupinski, N. Rovira, M. Chowdhury, F. Serracino-Inglott, L. Badimon. (2014). Novel methods for accurate identification, isolation, and genomic analysis of symptomatic microenvironments in atherosclerotic arteries. Methods Mol Biol. 1135, pp.289-305.
R. de la Torre, E. Peña, G. Vilahur, M. Slevin, L. Badimon (2013). Monomerization of C-reactive protein requires glycoprotein IIb-IIIa activation: pentraxins and platelet deposition. J Thromb Haemost. 11(11), pp.2048-2058.
A. Bosutti, J. Qi, R. Pennucci, D. Bolton, S. Matou, et al. K. Ali, LH. Tsai, J. Krupinski, EB. Petcu, J. Montaner, R. Al Baradie, F. Caccuri, A. Caruso, G. Alessandri, S. Kumar, C. Rodriguez, J. Martinez-Gonzalez, M. Slevin. (2013). Targeting p35/Cdk5 Signalling via CIP-Peptide Promotes Angiogenesis in Hypoxia. PLoS ONE. 8(9),
SE. Navone, G. Marfia, G. Invernici, S. Cristini, S. Nava, et al. S. Balbi, S. Sangiorgi, E. Ciusani, A. Bosutti, G. Alessandri, M. Slevin, EA. Parati. (2013). Isolation and expansion of human and mouse brain microvascular endothelial cells. NATURE PROTOCOLS. 8(9), pp.1680-1693.
SE. Navone, G. Marfia, S. Nava, G. Invernici, S. Cristini, et al. S. Balbi, S. Sangiorgi, E. Ciusani, A. Bosutti, G. Alessandri, M. Slevin, EA. Parati. (2013). Human and mouse brain-derived endothelial cells require high levels of growth factors medium for their isolation, in vitro maintenance and survival. Vascular Cell. 5(1),
A. Benjama, S. Matou-Nasri, N. Ahmed, M. Slevin (2013). Glycation of opticin: possible role in diabetic retinopathy. DIABETIC MEDICINE. 30, pp.62-62.
N. Ali, S. Matou-Nasri, M. Slevin, A. Nessar (2013). Effect of simvastatin on advanced glycation end-product induced angiogenesis. DIABETIC MEDICINE. 30, pp.65-65.
D. Sharma, S. Ivanovski, M. Slevin, S. Hamlet, TS. Pop, et al. K. Brinzaniuc, EB. Petcu, RI. Miroiu. (2013). Bisphosphonate-related osteonecrosis of jaw (BRONJ): diagnostic criteria and possible pathogenic mechanisms of an unexpected anti-angiogenic side effect. Vascular Cell. 5(1),
J. Krupinski, M. Slevin (2013). Emerging molecular targets for brain repair after stroke. Stroke Research and Treatment. 2013,
J. Krupinski, M. Abudawood, S. Matou-Nasri, R. Al-Baradie, EB. Petcu, et al. C. Justicia, A. Planas, D. Liu, N. Rovira, M. Grau-Slevin, J. Secades, M. Slevin. (2012). Citicoline induces angiogenesis improving survival of vascular/human brain microvessel endothelial cells through pathways involving ERK1/2 and insulin receptor substrate-1. Vascular Cell. 4(1), pp.20-20.
M. Slevin (2012). Potential of nanotechnology in vascular imaging and treatment of atherosclerosis. pp.3-9.
M. Slevin (2012). Current advances in the medical application of nanotechnology. Current Advances in the Medical Application of Nanotechnology.
HM. Alkreathy, ZA. Damanhouri, N. Ahmed, M. Slevin, AMM. Osman (2012). Mechanisms of cardioprotective effect of aged garlic extract against doxorubicin-induced cardiotoxicity. Integrative Cancer Therapies. 11(4), pp.364-370.
J. Montaner, T. García-Berrocoso, M. Mendioroz, M. Palacios, M. Perea-Gainza, et al. P. Delgado, A. Rosell, M. Slevin, M. Ribó, CA. Molina, J. Alvarez-Sabín. (2012). Brain natriuretic peptide is associated with worsening and mortality in acute stroke patients but adds no prognostic value to clinical predictors of outcome. Cerebrovascular Diseases. 34(3), pp.240-245.
F. Caccuri, C. Giagulli, A. Bugatti, A. Benetti, G. Alessandri, et al. D. Ribatti, S. Marsico, P. Apostoli, MA. Slevin, M. Rusnati, CA. Guzman, S. Fiorentini, A. Caruso. (2012). HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2. Proc Natl Acad Sci U S A. 109(36), pp.14580-14585.
EB. Petcu, A. Gonzalez-Serva, RG. Wright, M. Slevin, K. Brinzaniuc (2012). Prostate carcinoma metastatic to the skin as an extrammamary Paget's disease. Diagnostic Pathology. 7,
M. Di Napoli, DA. Godoy, V. Campi, L. Masotti, CJ. Smith, et al. ARP. Jones, SJ. Hopkins, M. Slevin, F. Papa, L. Mogoanta, D. Pirici, AP. Wagner. (2012). C-reactive protein in intracerebral hemorrhage: Time course, tissue localization, and prognosis. Neurology. 79(7), pp.690-699.
MM. Le Goff, MJ. Sutton, M. Slevin, A. Latif, MJ. Humphries, et al. PN. Bishop. (2012). Opticin exerts its anti-angiogenic activity by regulating extracellular matrix adhesiveness. J Biol Chem. 287(33), pp.28027-28036.
EB. Petcu, S. Ivanovski, RG. Wright, M. Slevin, RI. Miroiu, et al. K. Brinzaniuc. (2012). Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?. Diagnostic Pathology. 7,
M. Slevin, N. Ahmed, Q. Wang, G. McDowell, L. Badimon (2012). Unique vascular protective properties of natural products: supplements or future main-line drugs with significant anti-atherosclerotic potential?. Vasc Cell. 4(1),
A. Luque, MM. Turu, N. Rovira, JO. Juan-Babot, M. Slevin, et al. J. Krupinski. (2012). Early atherosclerotic plaques show evidence of infection by Chlamydia pneumoniae. Frontiers in Bioscience - Elite. 4 E(7), pp.2423-2432.
C. Mashilipa, Q. Wang, M. Slevin, N. Ahmed (2011). Antiglycation and antioxidant properties of soy sauces. J Med Food. 14(12), pp.1647-1653.
G. McDowell, M. Slevin, J. Krupinski (2011). Nanotechnology for the treatment of coronary in stent restenosis: A clinical perspective. Vascular Cell. 3,
J. Kitajewski, Y. Cao, M. Slevin (2011). It's hard to keep all things angiogenic in one JAR!. Vascular Cell. 3,
M. Slevin, L. Badimon, M. Grau-Olivares, M. Morrison, J. Krupinski (2011). Nanotechnology as a basis for the vascular treatment of atherosclerosis. International Journal of Nanotechnology. 8(8-9), pp.618-630.
H. Degens, A. Bosutti, SF. Gilliver, M. Slevin, A. van Heijst, et al. RCI. Wüst. (2010). Changes in contractile properties of skinned single rat soleus and diaphragm fibres after chronic hypoxia. Pflugers Arch. 460(5), pp.863-873.
SS. Mudan, A. Giakoustidis, D. Giakoustidis, M. Slevin (2010). Synchronous oesophagectomy and hepatic resection for metastatic oesophageal cancer: report of a case. Hippokratia. 14(4), pp.291-293.
M. Chowdhury, J. Ghosh, M. Slevin, JV. Smyth, MY. Alexander, et al. F. Serracino-Inglott. (2010). A Comparative Study of Carotid Atherosclerotic Plaque Microvessel Density and Angiogenic Growth Factor Expression in Symptomatic Versus Asymptomatic Patients. European Journal of Vascular and Endovascular Surgery. 39(4), pp.388-395.
J. Gaffney, S. Matou-Nasri, M. Grau-Olivares, M. Slevin (2010). Therapeutic applications of hyaluronan. Mol Biosyst. 6(3), pp.437-443.
M. Slevin, L. Badimon, M. Grau-Olivares, M. Ramis, J. Sendra, et al. M. Morrison, J. Krupinski. (2010). Combining nanotechnology with current biomedical knowledge for the vascular imaging and treatment of atherosclerosis. Mol Biosyst. 6(3), pp.444-450.
H. Alkreathy, ZA. Damanhouri, N. Ahmed, M. Slevin, SS. Ali, et al. AMM. Osman. (2010). Aged garlic extract protects against doxorubicin-induced cardiotoxicity in rats. Food and Chemical Toxicology. 48(3), pp.951-956.
AD. Almeida, HM. Wise, CJ. Hindley, MK. Slevin, RS. Hartley, et al. A. Philpott. (2010). The F-box protein Cdc4/Fbxw7 is a novel regulator of neural crest development in Xenopus laevis. Neural Development. 5(1),
M. Grau-Slevin, A. Arboix, J. Gaffney, M. Slevin (2010). The role of small vessel disease in development of Alzheimer's disease. Neural Regeneration Research. 5(4), pp.310-320.
M. Slevin, MM. Turu, N. Rovira, A. Luque, M. Baldellou, et al. J. Krupinski, L. Badimon. (2010). Identification of a 'snapshot' of co-expressed angiogenic markers in laser-dissected vessels from unstable carotid plaques with targeted arrays. J Vasc Res. 47(4), pp.323-335.
M. Slevin, S. Matou-Nasri, M. Turu, A. Luque, N. Rovira, et al. L. Badimon, S. Boluda, L. Potempa, C. Sanfeliu, N. de Vera, J. Krupinski. (2010). Modified C-reactive protein is expressed by stroke neovessels and is a potent activator of angiogenesis in vitro. Brain Pathol. 20(1), pp.151-165.
A. Bosutti, R. Pennucci, S. Matou, J. Gaffney, S. Love, et al. L-H. Tsai, KP. Giese, S. Kumar, J. Krupinski, M. Slevin. (2010). P35/Cdk5: two critical players in cytoskeletal/cell junction stability in human brain endothelial cell angiogenesis. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 26, pp.S68-S68.
M. Slevin, J. Krupinski (2009). A role for monomeric C-reactive protein in regulation of angiogenesis, endothelial cell inflammation and thrombus formation in cardiovascular/cerebrovascular disease?. Histol Histopathol. 24(11), pp.1473-1478.
M. Slevin, Y. Cao, J. Kitajewski (2009). Welcome to Journal of Angiogenesis Research. Journal of Angiogenesis Research (now Vascular Cell). 1(1),
A. Luque, M. Slevin, MM. Turu, O. Juan-Babot, L. Badimon, et al. J. Krupinski. (2009). CD105 positive neovessels are prevalent in early stage carotid lesions, and correlate with the grade in more advanced carotid and coronary plaques. J Angiogenes Res. 1,
M. Slevin, J. Krupinski, L. Badimon (2009). Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention. J Angiogenes Res. 1,
. Slevin (2009). Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and γ-adducin. International Journal of Oncology. 35(4),
E. Cuadrado, A. Rosell, A. Penalba, M. Slevin, J. Alvarez-Sabín, et al. A. Ortega-Aznar, J. Montaner. (2009). Vascular MMP-9/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: A combined laser microdissection and protein array study. Journal of Proteome Research. 8(6), pp.3191-3197.
M. Slevin, C. Sanfeliu, MM. Turu, M. Grau-Olivares, I. Ferrer, et al. S. Boluda, J. Marti-Fabregas, S. Kumar, P. Kumar, J. Krupinski. (2009). B-cell translocation gene 2 is over-expressed in peri-infarct neurons after ischaemic stroke. Pathobiology. 76(3), pp.129-135.
S. Hussain, M. Slevin, N. Ahmed, D. West, MI. Choudhary, et al. H. Naz, J. Gaffney. (2009). Stilbene glycosides are natural product inhibitors of FGF-2-induced angiogenesis. BMC Cell Biol. 10,
M. Slevin, J. Krupinski (2009). Cyclin-dependent kinase-5 targeting for ischaemic stroke. Curr Opin Pharmacol. 9(2), pp.119-124.
M. Slevin, J. Krupinski, N. Rovira, M. Turu, A. Luque, et al. M. Baldellou, C. Sanfeliu, N. de Vera, L. Badimon. (2009). Identification of pro-angiogenic markers in blood vessels from stroked-affected brain tissue using laser-capture microdissection. BMC Genomics. 10,
Q. Wang, J. Upton, W-H. Fang, M. Slevin, P. Kumar (2009). PAX3 ISOFORMS REGULATE WNT AND NOTCH SIGNALLING PATHWAYS IN EMBRYONIC STEM CELLS IN VITRO. IUBMB LIFE. 61(3), pp.305-305.
P. Kumar, Q. Wang, H. Li, W-H. Fang, M. Slevin, et al. S. Kumar. (2009). A NOVEL INVESTIGATION OF PAX3 FUNCTION IN EMBRYONIC CELL LINES UNDERGOING DIFFERENT DIFFERENTIATION PATHWAYS AND THE CORRESPONDING TUMOURS. IUBMB LIFE. 61(3), pp.305-305.
C. Rodríguez, M. Slevin, R. Rodríguez-Calvo, S. Kumar, J. Krupinski, et al. T. Tejerina, J. Martínez-González. (2009). Modulation of endothelium and endothelial progenitor cell function by low-density lipoproteins: Implication for vascular repair, angiogenesis and vasculogenesis. Pathobiology. 76(1), pp.11-22.
S. Hussain, J. Gaffney, N. Ahmed, M. Slevin, M. Iqbal Choudhary, et al. VU. Ahmad, Z. Qasmi, MA. Abbasi. (2009). An investigation of the kinetic and anti-angiogenic properties of plant glycoside inhibitors of thymidine phosphorylase. J Asian Nat Prod Res. 11(2), pp.159-167.
MA. Font, A. Fernandez, A. Carvajal, C. Gamez, L. Badimon, et al. M. Slevin, J. Krupinski. (2009). Imaging of early inflammation in low-to-moderate carotid stenosis by 18-FDG-PET. Frontiers in Bioscience. 14(9), pp.3352-3360.
Q. Wang, W-H. Fang, J. Krupinski, S. Kumar, M. Slevin, et al. P. Kumar. (2008). Pax genes in embryogenesis and oncogenesis. J Cell Mol Med. 12(6A), pp.2281-2294.
B. Molins, E. Peña, G. Vilahur, C. Mendieta, M. Slevin, et al. L. Badimon. (2008). C-Reactive Protein Isoforms Differ in Their Effects on Thrombus Growth. Arteriosclerosis, Thrombosis, and Vascular Biology. 28(12), pp.2239-2246.
M. Slevin (2008). Cerebral ischaemia in pituitary apoplexy - Commentary. Acta Neurochirurgica. 150(11),
J. Krupinski, MM. Turu, A. Luque, L. Badimon, M. Slevin (2008). Increased PrPC expression correlates with endoglin (CD105) positive microvessels in advanced carotid lesions. Acta Neuropathologica. 116(5), pp.537-545.
MM. Turu, M. Slevin, S. Matou, D. West, C. Rodríguez, et al. A. Luque, M. Grau-Olivares, L. Badimon, J. Martinez-Gonzalez, J. Krupinski. (2008). C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression. BMC Cell Biology. 9(47),
P. Kumar, Q. Wang, H. Li, W-H. Fang, M. Slevin, et al. S. Kumar. (2008). A NOVEL INVESTIGATION OF PAX3 FUNCTION IN EMBRYONIC CELL LINES UNDERGOING DIFFERENT DIFFERENTIATION PATHWAYS AND THE CORRESPONDING TUMOURS. ANTICANCER RESEARCH. 28(5C), pp.3362-3363.
M. Slevin, P. Kumar, Q. Wang, S. Kumar, J. Gaffney, et al. M. Grau-Olivares, J. Krupinski. (2008). New VEGF antagonists as possible therapeutic agents in vascular disease. Expert Opin Investig Drugs. 17(9), pp.1301-1314.
S. Kumar, M. Slevin, P. Kumar, Q. Wang (2008). Transcription factor PAX3 isoforms differentially regulate expression of the proto-oncogene c-Met in vitro. European Journal of Cancer Supplements. 6(9), pp.145-145.
J. Krupinski, P. Ethirajan, MA. Font, MM. Turu, J. Gaffney, et al. P. Kumar, M. Slevin. (2008). Changes in Hyaluronan Metabolism and RHAMM Receptor Expression Accompany Formation of Complicated Carotid Lesions and May be Pro-Angiogenic Mediators of Intimal Neovessel Growth. Biomark Insights. 2, pp.361-367.
M. Turu, M. Slevin, S. Matou, C. RodrIguez, A. Luque, et al. L. Badimon, J. MartInez-Gonzalez, J. Krupinski. (2008). C-REACTIVE PROTEIN EXERTS POTENT ANGIOGENIC EFFECTS ON HUMAN VASCULAR ENDOTHELIAL CELLS. ATHEROSCLEROSIS SUPPLEMENTS. 9(1), pp.67-67.
P. Ethirajan, J. Gaffney, P. Kumar, M. Slevin (2008). INCREASED PERFORIN EXPRESSION IN HUMAN ATHEROSCLEROTIC PLAQUES. ATHEROSCLEROSIS SUPPLEMENTS. 9(1), pp.48-48.
M. Slevin, P. Ethirajan, M. Molki, J. Gaffney, S. Kumar, et al. P. Kumar, J. Krupinski. (2008). Dynamin and perforin are associated with neovascularisation in advanced carotid plaques. Front Biosci. 13, pp.6515-6519.
J. Krupinski, A. Font, A. Luque, M. Turu, M. Slevin (2008). Angiogenesis and inflammation in carotid atherosclerosis. Frontiers in Bioscience. 13(17), pp.6472-6482.
M. Miguel Turu, J. Martínez González, A. Luque, A. Carvajal, JO. Juan-Babot, et al. MA. Font, E. Iborra, M. Slevin, F. Rubio, L. Badimón, J. Krupinski. (2008). Expression of C-reactive protein in atherosclerotic carotid plaques. Clinica e Investigacion en Arteriosclerosis. 20(3), pp.95-101.
A. Luque, M. Turu, O. Juan-Babot, P. Cardona, A. Font, et al. A. Carvajal, M. Slevin, E. Iborra, F. Rubio, L. Badimon, J. Krupinski. (2008). Overexpression of hypoxia/inflammatory markers in atherosclerotic carotid plaques. Frontiers in Bioscience. 13(17), pp.6483-6490.
M. Turu, M. Slevin, P. Ethirajan, A. Luque, A. Elasbali, et al. A. Font, J. Gaffney, M. Cairols, P. Kumar, S. Kumar, J. Krupinski. (2008). The normal cellular prion protein and its possible role in angiogenesis. Frontiers in Bioscience. 13(17), pp.6491-6500.
J. Krupinski, MM. Turu, M. Slevin, J. Martínez-González (2008). Carotid plaque, stroke pathogenesis, and CRP: treatment of ischemic stroke. Curr Cardiol Rep. 10(1), pp.25-30.
J. Krupinski, MM. Turu, MA. Font, E. Catena, M. Slevin, et al. S. Morchon, F. Rubio, L. Badimon, J. Martínez-González. (2008). Blood-borne tissue factor activity predicts major cerebrovascular events in patients undergoing carotid endarterectomy: Results from a 1-year follow-up study. Cerebrovascular Diseases. 25(1-2), pp.32-39.
S. Hussain, M. Slevin, MA. Mesaik, MI. Choudhary, AH. Elosta, et al. S. Matou, N. Ahmed, D. West, J. Gaffney. (2008). Cheiradone: a vascular endothelial cell growth factor receptor antagonist. BMC Cell Biol. 9,
N. Ahmed, C. Mashilipa, M. Slevin, CA. Smith (2008). Soy sauce inhibits protein glycation in vitro. The FEBS Journal. 275, pp.384-384.
M. Slevin, Q. Wang, MA. Font, A. Luque, O. Juan-Babot, et al. J. Gaffney, P. Kumar, S. Kumar, L. Badimon, J. Krupinski. (2008). Atherothrombosis and plaque heterology: different location or a unique disease?. Pathobiology. 75(4), pp.209-225.
S. Hussain, M. Slevin, S. Matou, N. Ahmed, MI. Choudhary, et al. R. Ranjit, D. West, J. Gaffney. (2008). Anti-angiogenic activity of sesterterpenes; natural product inhibitors of FGF-2-induced angiogenesis. Angiogenesis. 11(3), pp.245-256.
M. Slevin, J. Krupinski, N. Mitsios, C. Perikleous, E. Cuadrado, et al. J. Montaner, C. Sanfeliu, A. Luque, S. Kumar, P. Kumar, J. Gaffney. (2008). Leukaemia inhibitory factor is over-expressed by ischaemic brain tissue concomitant with reduced plasma expression following acute stroke. Eur J Neurol. 15(1), pp.29-37.
M. Slevin, J. Krupinski, N. Mitsios, C. Perikleous, E. Cuadrado, et al. J. Montaner, C. Sanfeliu, A. Luque, S. Kumar, P. Kumar, J. Gaffney. (2008). Leukaemia inhibitory factor is over-expressed by ischaemic brain tissue concomitant with reduced plasma expression following acute stroke. European Journal of Neurology. 15(1), pp.29-37.
M. Slevin, M. Grau-Olivares, J. Gaffney, P. Kumar, S. Hussain, et al. S. Kumar, J. Krupinski. (2007). Does cyclic dependent kinase 5 play a significant role in determination of stroke outcome? Possible therapeutic implications. Central Nervous System Agents in Medicinal Chemistry. 7(4), pp.251-258.
N. Mitsios, M. Saka, J. Krupinski, R. Pennucci, C. Sanfeliu, et al. Q. Wang, F. Rubio, J. Gaffney, P. Kumar, S. Kumar, M. Sullivan, M. Slevin. (2007). A microarray study of gene and protein regulation in human and rat brain following middle cerebral artery occlusion. BMC Neurosci. 8,
HG. Li, Q. Wang, HM. Li, S. Kumar, C. Parker, et al. M. Slevin, P. Kumar. (2007). PAX3 and PAX3-FKHR promote rhabdomyosarcoma cell survival through downregulation of PTEN. Cancer Lett. 253(2), pp.215-223.
J. Krupinski, MM. Turu, M. Slevin, J. Martínez-González (2007). Carotid plaque, stroke pathogenesis, and CRP: treatment of ischemic stroke. Curr Treat Options Cardiovasc Med. 9(3), pp.229-235.
J. Krupinski, MM. Turu, J. Martínez-González, A. Carvajal, JO. Juan-Babot, et al. E. Iborra, M. Slevin, F. Rubio, L. Badimón, V. Cachofeiro. (2007). Endogenous expression of C-reactive protein is increased in active (ulcerated noncomplicated) human carotid artery plaques. Clinica e Investigacion en Arteriosclerosis. 19(3), pp.154-155.
J. Krupinski, E. Catena, M. Miguel, P. Domenech, R. Vila, et al. S. Morchon, F. Rubio, M. Cairols, M. Slevin, L. Badimon. (2007). D-dimer local expression is increased in symptomatic patients undergoing carotid endarterectomy. International Journal of Cardiology. 116(2), pp.174-179.
Q. Wang, S. Kumar, N. Mitsios, M. Slevin, P. Kumar (2007). Investigation of downstream target genes of PAX3c, PAX3e and PAX3g isoforms in melanocytes by microarray analysis. Int J Cancer. 120(6), pp.1223-1231.
N. Mitsios, M. Saka, J. Krupinski, R. Pennucci, C. Sanfeliu, et al. M. Miguel Turu, J. Gaffney, P. Kumar, S. Kumar, M. Sullivan, M. Slevin. (2007). Cellular prion protein is increased in the plasma and peri-infarcted brain tissue after acute stroke. J Neurosci Res. 85(3), pp.602-611.
J. Stebbing, S. Slater, M. Slevin (2007). Breast cancer (metastatic). BMJ Clin Evid. 2007,
Y. Pastorello, M. Slevin Mesenchymal stem cell stroke therapy: current limitations in its clinical translation. Exploration of Neuroscience. pp.98-105.
J. Krupinski, P. Ethirajan, MA. Font, MM. Turu, J. Gaffney, et al. P. Kumar, M. Slevin. (2007). Changes in Hyaluronan Metabolism and RHAMM Receptor Expression Accompany Formation of Complicated Carotid Lesions and May be Pro-Angiogenic Mediators of Intimal Neovessel Growth. Biomarker Insights. 2, pp.117727190700200-117727190700200.
N. Mitsios, R. Pennucci, J. Krupinski, C. Sanfeliu, J. Gaffney, et al. P. Kumar, S. Kumar, O. Juan-Babot, M. Slevin. (2007). Expression of cyclin-dependent kinase 5 mRNA and protein in the human brain following acute ischemic stroke. Brain Pathol. 17(1), pp.11-23.
M. Slevin, J. Krupinski, J. Gaffney, S. Matou, D. West, et al. H. Delisser, RC. Savani, S. Kumar. (2007). Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol. 26(1), pp.58-68.
J. Krupinski, MM. Turu, MA. Font, N. Ahmed, M. Sullivan, et al. F. Rubio, L. Badimon, M. Slevin. (2007). Increased tissue factor, MMP-8, and D-dimer expression in diabetic patients with unstable advanced carotid atherosclerosis. Vasc Health Risk Manag. 3(4), pp.405-412.
N. Mitsios, J. Gaffney, J. Krupinski, R. Mathias, Q. Wang, et al. S. Hayward, F. Rubio, P. Kumar, S. Kumar, M. Slevin. (2007). Expression of signaling molecules associated with apoptosis in human ischemic stroke tissue. Cell Biochem Biophys. 47(1), pp.73-86.
Q. Wang, S. Kumar, M. Slevin, P. Kumar (2006). Functional analysis of alternative isoforms of the transcription factor PAX3 in melanocytes in vitro. Cancer Res. 66(17), pp.8574-8580.
N. Mitsios, R. Pennucci, J. Krupinski, C. Sanfeliu, J. Gaffney, et al. P. Kumar, S. Kumar, M. Slevin. (2006). Expression of cyclin-dependent kinase 5 and protein in the human brain following acute ischaemic stroke. EUROPEAN JOURNAL OF NEUROLOGY. 13, pp.51-51.
M. Slevin, P. Kumar, J. Gaffney, S. Kumar, J. Krupinski (2006). Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential. Clin Sci (Lond). 111(3), pp.171-183.
A. Al'Qteishat, J. Gaffney, J. Krupinski, F. Rubio, D. West, et al. S. Kumar, P. Kumar, N. Mitsios, M. Slevin. (2006). Changes in hyaluronan production and metabolism following ischaemic stroke in man. Brain. 129(Pt 8), pp.2158-2176.
A. Al Qteishat, JJ. Gaffney, J. Krupinski, M. Slevin (2006). Hyaluronan expression following middle cerebral artery occlusion in the rat. Neuroreport. 17(11), pp.1111-1114.
J. Zhang, M. Slevin, Y. Duraisamy, J. Gaffney, C. A Smith, et al. N. Ahmed. (2006). Comparison of protective effects of aspirin, D-penicillamine and vitamin E against high glucose-mediated toxicity in cultured endothelial cells. Biochim Biophys Acta. 1762(5), pp.551-557.
J. Krupinski, MM. Turu, J. Martinez-Gonzalez, A. Carvajal, JO. Juan-Babot, et al. E. Iborra, M. Slevin, F. Rubio, L. Badimon. (2006). Endogenous expression of C-reactive protein is increased in active (ulcerated noncomplicated) human carotid artery plaques. Stroke. 37(5), pp.1200-1204.
M. Slevin, AB. Elasbali, M. Miguel Turu, J. Krupinski, L. Badimon, et al. J. Gaffney. (2006). Identification of differential protein expression associated with development of unstable human carotid plaques. Am J Pathol. 168(3), pp.1004-1021.
N. Ahmed, J. Zhang, M. Slevin, Y. Duraisamy, C. Smith (2006). Aspirin, D-penicillamine and vitamin E preserve endothelial proliferation against glucose-mediated damage. The FEBS Journal. 273,
N. Ahmed, J. Zhang, M. Slevin, Y. Duraisamy, J. Gaffney, et al. C. Smith. (2006). Antiglycation compounds protect endothelial cell proliferation against glucose-mediated damage. The FEBS Journal. 273, pp.197-197.
N. Mitsios, J. Gaffney, P. Kumar, J. Krupinski, S. Kumar, et al. M. Slevin. (2006). Pathophysiology of acute ischaemic stroke: an analysis of common signalling mechanisms and identification of new molecular targets. Pathobiology. 73(4), pp.159-175.
W. Wang, M. Slevin, S. Kumar, P. Kumar (2005). The cooperative transforming effects of PAX3-FKHR and IGF-II on mouse myoblasts. Int J Oncol. 27(4), pp.1087-1096.
J. Krupinski, M. Slevin, L. Badimon (2005). Citicoline inhibits MAP kinase signalling pathways after focal cerebral ischaemia. Neurochemical Research. 30(8), pp.1067-1073.
J. ZHANG, M. SLEVIN, Y. DURAISAMY, CA. SMITH, J. GAFFNEY, et al. N. AHMED. (2005). High Glucose and Advanced Glycation End Products Inhibit the Proliferation of Cultured Endothelial Cells: Protection by Vitamin E. Annals of the New York Academy of Sciences. 1043(1), pp.947-947.
R. Issa, A. AlQteishat, N. Mitsios, M. Saka, J. Krupinski, et al. E. Tarkowski, J. Gaffney, M. Slevin, S. Kumar, P. Kumar. (2005). Expression of basic fibroblast growth factor mRNA and protein in the human brain following ischaemic stroke. Angiogenesis. 8(1), pp.53-62.
M. Slevin, J. Krupinski, P. Kumar, J. Gaffney, S. Kumar (2005). Gene activation and protein expression following ischaemic stroke: strategies towards neuroprotection. J Cell Mol Med. 9(1), pp.85-102.
Q. Wang, C. Parker, N. Mitsios, M. Slevin, S. Kumar, et al. P. Kumar. (2004). FUNCTIONAL ANALYSIS OF ALTERNATIVE ISOFORMS OF THE TRANSCRIPTION FACTOR PAX3 IN MELANOCYTES. ANTICANCER RESEARCH. 24(5D), pp.3543-3543.
B. Guo, P. Rooney, M. Slevin, C. Li, S. Parameshwar, et al. D. Liu, P. Kumar, C. Bernabeu, S. Kumar. (2004). Overexpression of CD105 in rat myoblasts: role of CD105 in cell attachment, spreading and survival. Int J Oncol. 25(2), pp.285-291.
M. Slevin, D. West, P. Kumar, P. Rooney, S. Kumar (2004). Hyaluronan, Angiogenesis and Malignant Disease [1]. International Journal of Cancer. 109(5), pp.793-794.
B. Guo, S. Kumar, C. Li, M. Slevin, P. Kumar (2004). CD105 (endoglin), apoptosis, and stroke. Stroke. 35(5), pp.e94-e95.
B. Guo, M. Slevin, C. Li, S. Parameshwar, D. Liu, et al. P. Kumar, C. Bernabeu, S. Kumar. (2004). CD105 inhibits transforming growth factor-β-Sma3 signalling. Anticancer Research. 24(3 A), pp.1337-1345.
J. Krupinski, P. Stroemer, M. Slevin, E. Marti, P. Kumar, et al. F. Rubio. (2003). Three-dimensional structure and survival of newly formed blood vessels after focal cerebral ischemia. NeuroReport. 14(8), pp.1171-1176.
J. Krupinski, M. Slevin, E. Marti, E. Catena, F. Rubio, et al. J. Gaffney. (2003). Time-course phosphorylation of the mitogen activated protein (MAP) kinase group of signalling proteins and related molecules following middle cerebral artery occlusion (MCAO) in rats. Neuropathology and Applied Neurobiology. 29(2), pp.144-158.
Y. Duraisamy, J. Gaffney, M. Slevin, CA. Smith, K. Williamson, et al. N. Ahmed. (2003). Aminosalicylic acid reduces the antiproliferative effect of hyperglycaemia, advanced glycation endproducts and glycated basic fibroblast growth factor in cultured bovine aortic endothelial cells: comparison with aminoguanidine. Mol Cell Biochem. 246(1-2), pp.143-153.
C. Quigley, S. Joel, N. Patel, A. Baksh, M. Slevin (2003). Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain. Palliat Med. 17(2), pp.185-190.
M. Slevin, S. Kumar, J. Gaffney (2002). Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem. 277(43), pp.41046-41059.
JA. Krupinski, EM. Puig, MA. Slevin, A. Slowik, A. Szczudlik (2001). Activation of MAP kinase (ERK-1/ERK-2), tyrosine kinase and VEGF in the human brain following acute ischaemic stroke. STROKE. 32(1), pp.355-355.
M. Slevin (2001). Serial measurement of vascular endothelial growth factor and transforming growth factor-beta 1 in serum of patients with acute ischemic stroke - Response. STROKE. 32(1), pp.277-277.
Y. Duraisamy, M. Slevin, N. Smith, J. Bailey, J. Zweit, et al. C. Smith, N. Ahmed, J. Gaffney. (2001). Effect of glycation on basic fibroblast growth factor induced angiogenesis and activation of associated signal transduction pathways in vascular endothelial cells: possible relevance to wound healing in diabetes. Angiogenesis. 4(4), pp.277-288.
M. Slevin, J. Krupinski, A. Slowik, F. Rubio, A. Szczudlik, et al. J. Gaffney. (2000). Activation of MAP kinase (ERK-1/ERK-2), tyrosine kinase and VEGF in the human brain following acute ischaemic stroke. Neuroreport. 11(12), pp.2759-2764.
M. Slevin, J. Krupinski, A. Slowik, P. Kumar, A. Szczudlik, et al. J. Gaffney. (2000). Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Stroke. 31(8), pp.1863-1870.
M. Slevin, S. Kumar, X. He, J. Gaffney (1999). Physiological concentrations of gangliosides GM1, GM2 and GM3 differentially modify basic-fibroblast-growth-factor-induced mitogenesis and the associated signalling pathway in endothelial cells. Int J Cancer. 82(3), pp.412-423.
M. Slevin, J. Krupinski, S. Kumar, J. Gaffney (1998). Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab Invest. 78(8), pp.987-1003.
J. Krupiński, MA. Slevin, P. Kumar, J. Gaffney, J. Kałuza (1998). Protein kinase C expression and activity in the human brain after ischaemic stroke. Acta Neurobiol Exp (Wars). 58(1), pp.13-21.
J. Krupinski, R. Issa, T. Bujny, M. Slevin, P. Kumar, et al. S. Kumar, J. Kaluza. (1997). A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans. Stroke. 28(3), pp.564-573.
M. Slevin (1996). The ganglioside profile of human bladder cell lines and the effect of exogenous gangliosides on their growth. International Journal of Oncology. 8(2), pp.275-281.
M. Slevin (1996). The ganglioside GM
BD. Edwards, MA. Slevin, AJ. Dickson, A. Ager, FW. Ballardie (1993). Antiproliferative actions of cyclosporin A on endothelial cells are not exerted through protein kinase C (PkC). Biochem Soc Trans. 21(4),
BD. Edwards, MA. Slevin, AJ. Dickson, A. Ager, FW. Ballardie (1993). Calphostin C inhibits endothelial cell proliferation and selectively modulates cell-surface marker expression. Biochem Soc Trans. 21(4),
M. Slevin, X. Sawkulycz, L. Combes, B. Guo, W-H. Fang, et al. Y. Zeinolabediny, D. Liu, G. Ferris, A. Ludlaim. (2020). Laser-Capture Microdissection for Measurement of Angiogenesis After Stroke. In: Neuromethods. Springer New York, pp.113-122.
M. Slevin, E. Bontas (2016). Arterial Graft Failure. In: Coronary Graft Failure. Springer International Publishing, pp.235-265.
S. Bradburn, JS. McPhee, A. Williams, S. Heffernan, S. Lockey, et al. S. Day, C. Murgatroyd. (2015). Protocol for Multiplex Amplicon Sequencing Using Barcoded Primers. M. Slevin, G. McDowell. In: Handbook of Vascular Biology Techniques. Springer Netherlands, pp.427-438.
G. McDowell, R. Body, C. Kirwan, G. Byrne, M. Slevin (2015). A Scheme for the Development and Validation of Enzyme Linked Immunosorbent Assays (ELISA) for Measurement of Angiogenic Biomarkers in Human Blood. In: Handbook of Vascular Biology Techniques. Springer Netherlands, pp.453-463.
E. Bray, M. Slevin (2015). Evaluating In Vitro Angiogenesis Using Live Cell Imaging. In: Handbook of Vascular Biology Techniques. Springer Netherlands, pp.29-43.
M. Slevin, M. Baldellou, E. Hill, Y. Alexander, G. McDowell, et al. C. Murgatroyd, M. Carroll, H. Degens, J. Krupinski, N. Rovira, M. Chowdhury, F. Serracino-Inglott, L. Badimon. (2014). Novel Methods for Accurate Identification, Isolation, and Genomic Analysis of Symptomatic Microenvironments in Atherosclerotic Arteries. In: Methods in Molecular Biology. Springer New York, pp.289-305.
M. Slevin, M. Carroll, C. Murgatroyd, G. McDowell (2014). Biophysical and Molecular Targets. In: Cardiac Arrhythmias. Springer London, pp.335-343.
M. Di Napoli, CJ. Smith, SJ. Hopkins, A. Popa-Wagner, AM. Buga, et al. M. Slevin. (2014). Neuroinflammation and Immune Regulation in Ischemic Stroke: Identification of New Pharmacological Targets. In: Neuroinflammation and Neurodegeneration. Springer New York, pp.199-244.
R. Ganderton, C. Monck, T. Wojdacz, M. Slevin, N. Meakin, et al. P. Grundy. (2021). A FEASIBILITY STUDY EVALUATING THE USE OF CELL-FREE DNA ANALYSIS IN LABORATORY BRAIN CANCER INVESTIGATIONS. In: NEURO-ONCOLOGY. ELECTR NETWORK, 8/7/2021. pp.25-25.
G. McDowell, A. McMullen, M. Al-Mashali, C. Austin, N. Dempsey-Hibbert, et al. M. Stout, M. Slevin, R. Body. (2020). 35 The (troponin) – manchester acute coronary syndrome rules in the emergency department systematic review and meta-analysis. In: Acute Coronary Syndromes & Interventional Cardiology. pp.A31-A32.
NR. Sproston, M. El Mohtadi, M. Slevin, W. Gilmore, JJ. Ashworth (2018). The effect of C-reactive protein isoforms on nitric oxide production by U937 monocytes/macrophages. In: Frontiers in Immunology.
NR. Sproston, M. El Mohtadi, M. Slevin, W. Gilmore, JJ. Ashworth (2018). The Effect of C-Reactive Protein Isoforms on Nitric Oxide Production by U937 Monocytes/Macrophages. In: Frontiers in immunology.
NR. Sproston, M. El Mohtadi, M. Slevin, W. Gilmore, JJ. Ashworth (2018). The Effect of C-Reactive Protein Isoforms on Nitric Oxide Production by U937 Monocytes/Macrophages. In: Front Immunol. Switzerland,
A. Aljohi, S. Matou-Nasri, N. Al-Khafaji, M. Slevin, N. Ahmed (2016). Momordica charantia (bitter melon) extracts promote angiogenesis in vitro via the receptor for advanced glycation endproducts (RAGE). Budapest, Hungary, 26/5/2016. pp.32-32.
M. Slevin (2014). G-105 P17 from HIV induces vascular cognitive decline and Alzheimer's-like degeneration in a mouse model of dementia. In: JAIDS Journal of Acquired Immune Deficiency Syndromes. Univ Maryland Sch Med, Baltimore, MD, 14/9/2014. pp.69-69.
N. Ahmed, H. Alkreathy, Z. Damanhouri, M. Slevin, AM. Osman (2014). Doxorubicin-induced cardiotoxicity: protection by aged garlic extract. Dana Point, California, 4/3/2014.
A. Benjama, S. Matou-Nasri, N. Ahmed, M. Slevin (2012). Glycation of opticin with methylglyoxal. Nancy, France, 16/9/2012.
N. Ali, S. Matou-Nasri, M. Slevin, N. Ahmed (2012). Effect of simvastatin on advanced glycation endproduct-induced angiogenesis. Nancy, France, 16/9/2012.
Q. Wang, AK. Fallah, J. Gaffney, P. Kumar, S. Kumar, et al. M. Slevin. (2012). Lysyl Oxidase: a Potential Therapeutic Target for Clear Cell Renal Cell Carcinoma. In: EUROPEAN JOURNAL OF CANCER. Barcelona, SPAIN, 7/7/2012. pp.S64-S64.
S. Matou-Nasri, J. Gaffney, E. Boras, J. Kuprinski, LA. Potempa, et al. M. Slevin. (2011). Monomeric C-reactive Protein-Induced Angiogenesis Requires Gamma-Secretase Activity, Operates Through The PI3K/Akt Pathway And May Potentiate Notch-3 Function In Promotion Of Blood Vessel Stability. In: STROKE. Los Angeles, CA, 8/2/2011. pp.E136-E136.
A. Bosutti, S. Matou, J. Qi, R. Pennucci, L-H. Tsai, et al. KP. Giese, S. Love, J. Krupinski, S. Kumar, M. Slevin. (2011). Over-Expression Of Cyclin-Dependent Kinase 5 Stimulates Cell Migration But Not Cell Differentiation In Human Brain Microvascular Endothelial Cells. In: STROKE. Los Angeles, CA, 8/2/2011. pp.E134-E134.
A. Luque, MM. Turu, M. Slevin, JO. Juan-Babot, N. Rovira, et al. A. Carvajal, MA. Font, J. Krupinski. (2011). Chlamydia Pneumoniae In Early Lesions Of Patients With Carotid Atherosclerosis. In: STROKE. Los Angeles, CA, 8/2/2011. pp.E189-E189.
EJR. Hill, M. Chowdhury, F. Serracino-Inglott, M. Slevin, MY. Alexander (2011). Analysis of microvessels within carotid artery to determine plaque stability. In: BRITISH JOURNAL OF SURGERY. Royal Coll Surgery, Dublin, IRELAND, 5/1/2011. pp.34-34.
EJR. Hill, M. Chowdhury, F. Serracino-Inglott, JV. Smyth, M. Slevin, et al. MY. Alexander. (2010). Microvessel analysis within endarterectomy specimens from symptomatic and asymptomatic patients to identify those at risk from plaque rupture. In: INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY. Univ Manchester, Manchester, ENGLAND, 29/3/2010. pp.A13-A13.
S. Matou-Nasri, N. Aziz, J. Gaffney, J. Kuprinski, M. Slevin (2010). Monomeric C-Reactive Protein and Notch-3 May Contribute to Vascular Development and Stability After Stroke. In: STROKE. San Antonio, TX, 23/2/2010. pp.E219-E219.
A. Bosutti, R. Pennucci, S. Matou, J. Gaffney, S. Love, et al. L-H. Tsai, KP. Giese, S. Kumar, J. Krupinski, M. Slevin. (2010). Alterations in Cyclin-dependent Kinase 5 Activator p35 Signaling Are Associated With Angiogenesis, in Brain Endothelial Cells. In: STROKE. San Antonio, TX, 23/2/2010. pp.E350-E350.
A. Bosutti, R. Pennucci, J. Krupinski, S. Kumar, P. Kumar, et al. M. Slevin. (2009). Involvement Of The Cyclin-dependent Kinase 5 In Microvascular Endothelial Cell Migration In Vitro. In: STROKE. San Diego, CA, 17/2/2009. pp.E141-E141.
A. Luque, MM. Turu, O. Juan-Babot, A. Carvajal, MA. Font, et al. M. Slevin, L. Badimon, J. Krupinski. (2009). Chlamydia Pneumoniae Infection Appears In A Very Early Carotid Lesions And Is Associated With Important Immune Responses. In: STROKE. San Diego, CA, 17/2/2009. pp.E184-E185.
C. Mashilipa, M. Slevin, N. Ahmed, CA. Smith (2008). Soy sauce inhibits protein glycation in vitro. In: FEBS JOURNAL. Athens, GREECE, 28/6/2008. pp.384-384.
MM. Le Goff, M. Slevin, P. McEwan, MJ. Humphries, PN. Bishop (2009). Opticin disrupts collagen-induced capillary morphogenesis by interacting with the alpha(2)beta(1) integrin. In: INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY. York Univ, York, ENGLAND, 7/4/2008. pp.A119-A120.
MA. Font, A. Fernandez, C. Gamez, M. Slevin, R. Vila, et al. E. Iborra, F. Rubio, J. Krupinski. (2008). (18)FDG-PET imaging of human carotid arteries prior to endarterectomy confirms it is a bilateral disease. In: STROKE. New Orleans, LA, 19/2/2008. pp.564-564.
J. Krupinski, MM. Turu, S. Matou, C. Rodriguez, J. Martinez-Gonzalez, et al. L. Badimon, A. Luque, M. Slevin. (2008). C-reactive protein exerts potent angiogenic effects on vascular endothelial cells. In: STROKE. New Orleans, LA, 19/2/2008. pp.566-566.
J. Abdullah, MA. Slevin, J. Gaffney, N. Ahmed (2007). Effect of epigallocatechin gallate on formation of advanced glycation endproducts in vitro. Munich, Germany, 1/9/2007. pp.155-155.
A. Elosta, M. Slevin, N. Ahmed (2007). The effect of aged garlic extract and S-allylcysteine on protein glycation: possible role in prevention of diabetic complications. Munich, Germany, 1/9/2007. pp.161-161.
C. Mashilipa, CA. Smith, M. Slevin, V. Edward-Jones, N. Ahmed (2007). Effect of soy sauce on glycation. Munich, Germany, 1/9/2007. pp.195-195.
N. Mitsios, M. Saka, J. Krupinski, R. Pennucci, C. Sanfeliu, et al. J. Gaffney, P. Kumar, S. Kumar, M. Slevin. (2007). A comparison of gene and protein regulation changes between human and a rat model of stroke using cDNA microarrays. In: JOURNAL OF NEUROCHEMISTRY. Cancun, MEXICO, 19/8/2007. pp.265-265.
P. Ethirajan, J. Gaffney, P. Kumar, J. Krupinski, M. Slevin (2007). Increased PRPC expression in human carotid artery lesions. In: ATHEROSCLEROSIS SUPPLEMENTS. Helsinki, FINLAND, 10/6/2007. pp.213-213.
M. Slevin, P. Ethirajan, P. Kumar, J. Gaffney, A. Elasbali, et al. J. Krupinski, MM. Turu. (2007). Prion protein is over-expressed in intimal neovessels of complicated carotid plaques. In: FASEB JOURNAL. Washington, DC, 28/4/2007. pp.A854-A854.
MJ. Sutton, M. le Goff, D. West, P. Bishop, M. Slevin (2007). Anti-angiogenic properties of opticin. In: FASEB JOURNAL. Washington, DC, 28/4/2007. pp.A528-A528.
J. Krupinski, P. Ethirajan, MM. Turu, A. Elasbali, MA. Font, et al. J. Gaffney, F. Rubio, M. Slevin. (2007). Normal prion protein involvement in angiogenic switch in human carotid artery plaques. In: STROKE. San Francisco, CA, 7/2/2007. pp.568-568.
MA. Font, A. Fernandez, MM. Turu, C. Gamez, M. Slevin, et al. F. Rubio, L. Badimon, J. Krupinski. (2007). Metabolic proinflammatory activity in human carotid artery plaques is detected by (18)FDG-PET imaging prior to endarterectomy. In: STROKE. San Francisco, CA, 7/2/2007. pp.587-587.
S. Hussain, N. Ahmed, Z. Ul-Haq, MI. Choudhary, M. Slevin (2006). Identification and characterisation of natural products as anti-angiogenic drug candidates. MMU, UK, 3/7/2006.
C. Mashilipa, MA. Slevin, V. Edward-Jones, N. Ahmed (2006). Role of hyperglycaemia in cellular and molecular changes underlying impaired wound healing in diabetes mellitus. MMU, UK, 3/7/2006.
C. Smith, J. Zhang, M. Slevin, Y. Duraisamy, J. Gaffney, et al. N. Ahmed. (2006). Aspirin, D-penicillamine and vitamin E preserve endothelial cell migration against high glucose. In: FEBS JOURNAL. Istanbul, TURKEY, 24/6/2006. pp.196-197.
N. Ahmed, J. Zhang, M. Slevin, Y. Duraisamy, J. Gaffney, et al. C. Smith. (2006). Antiglycation compounds protect endothelial cell proliferation against glucose-mediated damage. In: FEBS JOURNAL. Istanbul, TURKEY, 24/6/2006. pp.197-197.
P. Ethirajan, M. Slevin, J. Gaffney, P. Kumar, J. Verran (2006). Study of changes in gene and protein expression involved during the development of atherosclerotic plaques. In: ATHEROSCLEROSIS SUPPLEMENTS. Rome, ITALY, 18/6/2006. pp.246-246.
Y. Duraisamy, MA. Slevin, CA. Smith, J. Gaffney, N. Ahmed (2006). Effect of glycation on fibroblast growth factor-2 induced angiogenesis: relevance to diabetic wound healing. Naples, Italy, 24/5/2006. pp.47-47.
S. Matou, J. Gaffney, S. Kumar, M. Slevin (2006). Identification of hyaluronan-induced signaling pathways through RHAMM and CD44 receptors in vascular endothelial cells. In: FASEB JOURNAL. San Francisco, CA, 1/4/2006. pp.A1362-A1362.
M. Slevin, M. Le Goff, M. Sutton, D. West, P. Bishop (2006). Opticin is an anti-angiogenic component of the vitreous humour of the eye. In: FASEB JOURNAL. San Francisco, CA, 1/4/2006. pp.A980-A980.
N. Mitsios, R. Pennucci, J. Krupinski, C. Sanfeliu, J. Gaffney, et al. P. Kumar, S. Kumar, M. Slevin. (2006). Expression of cyclin-dependent kinase 5 mRNA and protein in the human brain following acute ischemic stroke. In: FASEB JOURNAL. San Francisco, CA, 1/4/2006. pp.A461-A461.
RL. Cowen, DJ. Cumiskey, MM. Le-Goff, MA. Slevin, D. West, et al. A. Siewart, O. McKenzie, IJ. Stratford, PN. Bishop. (2005). Opticin: A potential cancer therapeutic that directly inhibits tumor cell growth and suppresses angiogenesis. In: CLINICAL CANCER RESEARCH. Philadelphia, PA, 14/11/2005. pp.9034S-9034S.
P. Bishop, M. Slevin, D. West, D. Valdramidou, M. Humphries, et al. M. Le Goff. (2006). The anti-angiogenic properties of the ocular glycoprotein opticin. In: INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY. Univ Manchester, Hulme Hall, Manchester, ENGLAND, 12/9/2005. pp.A45-A45.
M. Sutton, MA. Slevin, J. Gaffney, N. Ahmed (2005). Anti-angiogenic properties of opticin. MMU, UK, 7/7/2005.
MA. Slevin, J. Gaffney, P. Kumar, S. Kurnar (2005). Comparison of changes in gene and protein regulation between human and rat models of stroke: Identification of novel 'human associated' markers of inflammation and apoptosis. In: FASEB JOURNAL. San Diego, CA, 31/3/2005. pp.A1706-A1707.
M. Saka, J. Gaffney, P. Kumar, S. Kumar, M. Slevin (2005). Changes in gene regulation and protein activation following acute ischaemic stroke in a rat middle cerebral artery occlusion model. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. Inst Child Hlth, London, ENGLAND, 12/1/2005. pp.236-236.
N. Mitsios, J. Gaffney, PM. Kumar, S. Kumar, M. Slevin (2005). A microarray study of gene expression in human brain after ischaemic stroke. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. Inst Child Hlth, London, ENGLAND, 12/1/2005. pp.236-236.
N. Mitsios, M. Saka, J. Gaffney, PM. Kumar, S. Kumar, et al. M. Slevin. (2005). A microarray study of gene expression in human brain after ischaemic stroke: identification of novel genes and comparison with the rat middle cerebral artery occlusion model of ischaemic stroke. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. Inst Child Hlth, London, ENGLAND, 12/1/2005. pp.225-226.
MM. Le Goff, MA. Slevin, MJ. Humphries, PN. Bishop (2005). Opticin disrupts capillary morphogenesis on collagen potentially through alpha(2)beta(1) integrin binding. In: INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY. Univ Liverpool, Liverpool, ENGLAND, 2005. pp.A79-A79.
J. Zhang, MA. Slevin, Y. Duraisamy, CA. Smith, J. Gaffney, et al. N. Ahmed. (2004). High glucose and advanced glycation endproducts inhibit proliferation of cultured endothelial cells: protection by vitamin E. Charleston, USA, 28/8/2004. pp.94-94.
MM. Le Goff, MA. Slevin, PN. Bishop (2004). The anti-angiogenic effects of opticin, a glycoprotein in the vitreous humour of the eye. In: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. Ft Lauderdale, FL, 24/4/2004. pp.U742-U742.
N. Ahmed, Y. Duraisamy, MA. Slevin, J. Gaffney, CA. Smith (2003). Advanced glycation endproducts induce cellular toxicity: protection by vitamin E. Busan, South Korea, 30/8/2003. pp.87-88.
MS. Ahmad, Y. Duraisamy, MA. Slevin, J. Gaffney, CA. Smith, et al. N. Ahmed. (2003). Dimethyl sulfoxide protects endothelial cells against advanced glycation endproduct-mediated toxicity. Essex, UK, 2/7/2003. pp.58-58.
N. Ahmed, Y. Duraisamy, MA. Slevin, J. Gaffney, CA. Smith (2003). Glycation of basic fibrolblast growth factor reduces its biological activity: implications for diabetic wound healing. In: Proceedings of the PSBMB 7th International Conference. Lahore, Pakistan, 2/4/2003. pp.23-23.